LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
ClosedPublished 11 Jul 2022

Innoviva, Inc. /
Entasis Therapeutics Holdings Inc.

Innoviva Completes Acquisition of Entasis Therapeutics Holdings Inc.

Terms
Not stated
Stage
Closed
Source · 11 Jul 2022
See the source
01 / BuyerInnoviva, Inc.
02 / TargetEntasis Therapeutics Holdings Inc.
01

What happened

Innoviva, Inc. completed its acquisition of Entasis Therapeutics Holdings Inc. on July 11, 2022. Entasis became a wholly-owned subsidiary of Innoviva.

The transaction's aggregate consideration was approximately $42,395,047.20. Entasis is an advanced late-stage clinical biopharmaceutical company focused on novel antibacterial products.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Innoviva Completes Acquisition of Entasis Therapeutics Holdings Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.